These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 7028307
1. Investigations on the mutagenicity of primary and secondary alpha-acetoxynitrosamines with Salmonella typhimurium: activation and deactivation of structurally related compounds by S-9. Pool BL, Wiessler M. Carcinogenesis; 1981; 2(10):991-7. PubMed ID: 7028307 [Abstract] [Full Text] [Related]
2. N-nitrosamines: bacterial mutagenesis and in vitro metabolism. Guttenplan JB. Mutat Res; 1987 Sep; 186(2):81-134. PubMed ID: 3306361 [Abstract] [Full Text] [Related]
3. Chemistry and mutagenicity of alpha-hydroxy nitrosamines. Mochizuki M, Anjo T, Takeda K, Suzuki E, Sekiguchi N, Huang GF, Okada M. IARC Sci Publ; 1982 Sep; (41):553-9. PubMed ID: 7141560 [Abstract] [Full Text] [Related]
4. The mutagenic properties of N-nitrosopeptides in the Ames test. Challis BC, Hopkins AR, Milligan JR, Massey RC, Anderson D, Blowers SD. Toxicol Lett; 1985 Aug; 26(2-3):89-93. PubMed ID: 3898471 [Abstract] [Full Text] [Related]
5. Metabolic activation capabilities of S9 and hepatocytes from uninduced rats to convert carcinogenic N-nitrosamines to mutagens. Rumruen K, Pool BL. Mutat Res; 1984 Aug; 140(2-3):147-53. PubMed ID: 6379440 [Abstract] [Full Text] [Related]
6. Mutagenicity studies on N-nitrosated products of the Maillard browning reaction: N-nitroso-fructose-amino acids. Pool BL, Röper H, Röper S, Romruen K. Food Chem Toxicol; 1984 Oct; 22(10):797-801. PubMed ID: 6386628 [Abstract] [Full Text] [Related]
7. Comparison of mutagenicities of N-nitrosamines on Salmonella typhimurium TA100 and Escherichia coli WP2 uvrA/pKM101 using rat and hamster liver s9. Araki A, Muramatsu M, Matsushima T. Gan; 1984 Jan; 75(1):8-16. PubMed ID: 6373472 [Abstract] [Full Text] [Related]
8. Mutagenicity of potassium alkanediazotates and their use as model compounds for activated nitrosamines. Hecker LI, Saavedra JE, Farrelly JG, Andrews AW. Cancer Res; 1983 Sep; 43(9):4078-82. PubMed ID: 6347365 [Abstract] [Full Text] [Related]
11. Activation of N-nitrosodialkylamines to mutagens by a metalloporphyrin/oxidant model system for cytochrome P450. Okochi E, Namai E, Ito K, Mochizuki M. Biol Pharm Bull; 1995 Jan; 18(1):49-52. PubMed ID: 7735249 [Abstract] [Full Text] [Related]
12. Mutagenicity of alpha-hydroxy N-nitrosamines in V79 Chinese hamster cells. Mochizuki M, Osabe M, Anjo T, Takeda K, Suzuki E, Okada M. IARC Sci Publ; 1984 Jan; (57):715-9. PubMed ID: 6398304 [Abstract] [Full Text] [Related]
17. Chemical and mutagenic properties of alpha-phosphonooxynitrosamines. Mochizuki M, Ikarashi A, Suzuki A, Sekiguchi N, Anjo T, Okada M. IARC Sci Publ; 1987 Jan; (84):165-9. PubMed ID: 3679360 [Abstract] [Full Text] [Related]
18. Inhibitory effect of organic solvents on the mutagenicity of N-nitrosodialkylamines in Salmonella. Mori Y, Yamazaki H, Toyoshi K, Emi Y, Uchida K, Tsutsumi M, Konishi Y. Mutat Res; 1985 Apr; 142(4):153-8. PubMed ID: 3885018 [Abstract] [Full Text] [Related]
19. [Study of promutagen biotransformation in the Ames test. III. The role of conjugation with glucuronic acid and sulfate in the modification of mutagenic effect of nitrosomorpholine, diethylnitrosamine and cyclophosphamide]. Loknitskaia NN, Rotenberg IuS, Fonshteĭn LM, Shuliakovskaia TS. Genetika; 1986 Sep; 22(9):2259-64. PubMed ID: 3533722 [Abstract] [Full Text] [Related]